Neuroprosthetics Market Size To Reach $34.90 Billion By 2030

Neuroprosthetics Market Growth & Trends

The global neuroprosthetics market size is expected to reach USD 34.90 billion by 2030, expanding at a CAGR of 15.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand for cost-effective and technologically advanced implants is expected to drive the demand for neuroprosthetics market in the coming years. 

In addition, the associated high costs and side effects of conventional medications are responsible for the rising adoption rate of implants. For instance, the increasing adoption of Vagus Nerve Stimulation (VNS) therapy system over therapeutics such as antidepressants in the treatment of Alzheimer's disease, brain aneurysm, and strokes is propelling the overall market growth. 

Moreover, the rising geriatric population prone to epilepsy opting for neural implantation over the conventional medication is exerting a positive effect on the overall industry growth.

 Request a free sample copy or view report summary: Neuroprosthetics Market Report

Neuroprosthetics Market Report Highlights

• The motor prosthetic devices segment dominated in terms of revenue share and accounted for over 42.8.0% of the market in 2023, followed by visual cochlear implants. Whereas, retinal neuroprosthetics were identified as one of the fastest growing market segment owing to the rising penetration and the increasing R&D efforts pertaining to product innovation.

• The Spinal Cord Stimulation (SCS) segment held the largest share at over 49.2% owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Furthermore, it finds applications in intraspinal and epidural microstimulation for inducing leg movements. In addition, technological advancements in this segment is expected to further boost market growth in the near future. The sacral Nerve Stimulation (SNS) is expected to be the fastest growing segment over the forecast period due to its applications in chronic intractable pelvic ache and neurogenic bladder.

• In the applications segment, motor neuron disorders held the largest segment due to the rising incidences of Parkinson’s disease and epilepsy. For instance, as per the report published by Parkinson’s disease Foundation in 2012, approximately 60,000 Americans were diagnosed with Parkinson’s disease each year and the number is expected to grow further over the forecast period thereby fueling this segment’s growth.

• In 2023, North America dominated the overall neuroprosthetics market at over 42.5% owing to the large presence of neural implants manufacturers, higher R&D investments, and the availability of funds from both government and private institutes. For instance, the Defense Advanced Research Project Agency (DARPA) and National Institute of Neurological Disorders and Stroke (NIH)in collaboration with the federal agencies are instrumental in providing funds to support R&D initiatives for the further development of neural implants.

• Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers

• Strategic collaborations and mergers & acquisitions are expected to keep the industry rivalry level high over the forecast period

Neuroprosthetics Market Segmentation

Grand View Research has segmented the global neuroprosthetics market based on type, technology, application, and region:

Neuroprosthetics Type Outlook (Revenue, USD Million, 2018 - 2030)

• Motor Prosthetics

• Cochlear Implants

• Cognitive Prosthetics

• Retinal Implants

Neuroprosthetics Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Deep Brain Stimulation (DBS)

• Vagus Nerve Stimulation (VNS)

• Spinal Cord Stimulation (SCS)

• Sacral Nerve Stimulation (SNS

Neuroprosthetics Application Outlook (Revenue, USD Million, 2018 - 2030) 

• Motor Neuron Disorders 

  • Parkinson’s Disease

  • Epilepsy

• Physiological Disorders

  • Auditory Disorders

  • Ophthalmic Disorders

  • Cardiac Disorders

  • Kidney Disorders

• Cognitive Disorders

  • Alzheimer’s Disease

  • Severe Depression

Neuroprosthetics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Mexico

  • Canada

• Europe

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Thailand

  • Australia

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Neuroprosthetics Market

• Medtronic Plc

• LivaNova

• Cochlear Ltd.

• Abbott Laboratories

• Boston Scientific

• NeuroPace, Inc.

• St. Jude Medical, Inc.,

• Retina Implant AG,

• Nervo Corp.,

• Sonova

• BrainGate